Last Verified: | June/30/2009 |
First Submitted: | July/21/2009 |
Estimated Enrollment Submitted: | July/21/2009 |
First Posted: | July/22/2009 |
Last Update Submitted: | July/22/2009 |
Last Update Posted: | July/23/2009 |
Actual Study Start Date: | August/31/2009 |
Estimated Primary Completion Date: | November/30/2009 |
Estimated Study Completion Date: | December/31/2009 |
Study Type: | Interventional |
Allocation: | Randomized |
Primary Purpose: | Treatment |
Masking: | None (Open Label) |
Arm | Intervention/treatment |
---|---|
Experimental: Liquid and solid | Drug: Liquid and solid Comparison of different pharmaceutics forms of drug |
Ages Eligible for Study: | 18 Years to 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria: | Inclusion Criteria: - Patients who achieve scores between 18 and 29 points in the Hamilton Scale for Anxiety; - Individuals of any ethnic group male and female, aged above 18 years; - Consent of the subject of research (a consent form signed). Exclusion Criteria: - Patients with known hypersensitivity to any components of the formula; - Pregnant women and nursing mothers; - Patients with endogenous depression, schizophrenia, suicidal tendency; - Patients with heart disease unabated, unabated kidney, liver and lung unabated unabated, at the discretion of the investigator; - Addiction to drugs, including alcohol, at the discretion of the investigator; - Patients who are using any medication that could interfere with the effect of the drug under study; - Impossibility of compliance to the protocol |